CHRISTIE LOUIS: Open Payments
NPI 1720312564 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$585 in 35 payments from 10 companies in 2025. Trend: 2023 $1,677 · 2024 $288 · 2025 $585
Food & beverage: $585
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 15 | $233 |
| Astellas Pharma US Inc | 8 | $135 |
| Pacira Pharmaceuticals Incorporated | 2 | $43 |
| Dexcom, Inc. | 2 | $38 |
| Exeltis, USA Inc. | 2 | $38 |
| Medtronic, Inc. | 1 | $23 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $16 |
| Evofem Biosciences, Inc. | 2 | $14 |
Products named: GEMTESA, Veozah, MYFEMBREE, Exparel, Dexcom G6 Transmitter, SLYND, TRUCLEAR, APTIMA.
Industry payments across TX — which companies pay providers there.
